SE7900738L - PHARMACEUTICAL AGENT - Google Patents

PHARMACEUTICAL AGENT

Info

Publication number
SE7900738L
SE7900738L SE7900738A SE7900738A SE7900738L SE 7900738 L SE7900738 L SE 7900738L SE 7900738 A SE7900738 A SE 7900738A SE 7900738 A SE7900738 A SE 7900738A SE 7900738 L SE7900738 L SE 7900738L
Authority
SE
Sweden
Prior art keywords
cross
linked
salicylazosulfa
pyridine
dextran
Prior art date
Application number
SE7900738A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE431937B (en
Inventor
J A O Johansson
Original Assignee
Perstorp Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp Ab filed Critical Perstorp Ab
Priority to SE7900738A priority Critical patent/SE431937B/en
Priority to GB8001484A priority patent/GB2041958B/en
Priority to DE19803003107 priority patent/DE3003107A1/en
Publication of SE7900738L publication Critical patent/SE7900738L/en
Publication of SE431937B publication Critical patent/SE431937B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A salicylazosulfa pyridine containing medical preparation, principally intended for treatment of ulcerous colitis, comprises salicylazosulfa pyridine chemically bonded, absorbed or adsorbed in a hydrophilic, cross-linked hydroxyl group containing polymer which is insoluble in water but has a capability of swelling in water containing liquids while forming a gel with chromatographic qualities. The polymer is preferably a cross-linked cellulose, starch, inulin, dextran or derivative, eg ethylhydroxyethyl cellulose, hydroxypropyl starch or hydroxyethyl dextran, or a polymerized and cross- linked carbohydrate, eg. dextrin, saccharose, maltose, glucose, fructose, sorbitol or inositol.
SE7900738A 1979-01-29 1979-01-29 SALICYLAZOSULPHAPYRIDE CONTAINING MEDICAL PREPARATION SE431937B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE7900738A SE431937B (en) 1979-01-29 1979-01-29 SALICYLAZOSULPHAPYRIDE CONTAINING MEDICAL PREPARATION
GB8001484A GB2041958B (en) 1979-01-29 1980-01-16 Medical preparations containing salicylazosulpha pyridine
DE19803003107 DE3003107A1 (en) 1979-01-29 1980-01-29 SALICYLAZOSULFAPYRIDINE CONTAINING MEDICINAL PRODUCT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7900738A SE431937B (en) 1979-01-29 1979-01-29 SALICYLAZOSULPHAPYRIDE CONTAINING MEDICAL PREPARATION

Publications (2)

Publication Number Publication Date
SE7900738L true SE7900738L (en) 1980-07-30
SE431937B SE431937B (en) 1984-03-12

Family

ID=20337130

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7900738A SE431937B (en) 1979-01-29 1979-01-29 SALICYLAZOSULPHAPYRIDE CONTAINING MEDICAL PREPARATION

Country Status (3)

Country Link
DE (1) DE3003107A1 (en)
GB (1) GB2041958B (en)
SE (1) SE431937B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1131833B (en) * 1980-06-20 1986-06-25 Crinos Industria Farmaco EXCIPIENTS FOR SPERMICIDE SUBSTANCES
DK130287D0 (en) * 1987-03-13 1987-03-13 Benzon As Alfred ORAL PREPARATION
US5288500A (en) * 1987-03-13 1994-02-22 Benzon Pharma A/S Oral composition containing particles comprising an active substance
DK110188D0 (en) * 1988-03-02 1988-03-02 Claus Selch Larsen HIGH MOLECULAR WEIGHT PRODRUG DERIVATIVES OF ANTI-FLAMMATORY DRUGS
CN104130186A (en) * 2014-06-30 2014-11-05 江苏瑞克医药科技有限公司 Method for improving salicylazosulfapyridine refining production efficiency
CN105348184B (en) * 2015-11-26 2020-12-29 苏州统华药品有限公司 Preparation method of sulfasalazine

Also Published As

Publication number Publication date
GB2041958B (en) 1982-11-24
GB2041958A (en) 1980-09-17
SE431937B (en) 1984-03-12
DE3003107A1 (en) 1980-08-07

Similar Documents

Publication Publication Date Title
US5603956A (en) Cross-linked enzymatically controlled drug release
GB1454055A (en) Preparation ofr treating fluid-discharging skin surfaces wounds sores and mucous membranes
NO971688L (en) Solid delivery systems for controlled release of molecules incorporated therein and processes for their preparation
NL190693C (en) Stable prostaglandin-containing pharmaceutical preparation.
AU7115394A (en) Dried hydrogel from hydrophylic-hygroscopic polymer
DE69125609T2 (en) Water-insoluble hyaluronic acid derivatives
DE69326234T2 (en) MEDICINE SYSTEM WITH GEL MATRIX CONTAINING AN IMMOBILIZED ACTIVE SUBSTANCE
JPS5451596A (en) Chromatography material
SE7900738L (en) PHARMACEUTICAL AGENT
AU469963B2 (en) Treatment of cellulosic matter with activated nitrogen or other activated gases
SE8202439L (en) 4'-IODINE DERIVATIVES OF ANTRACYCLING GYCOSIDES
ZA705481B (en) Process and diagnostic agent for the enzymatic determination of glucose
CA980971A (en) Structural unit body having pipe incorporated thereinto and structure assembled thereof
GB1349394A (en) Preswelled cellulose films and process therefor
CA1000587A (en) Cold pressure weld, and low-pressure piping system capable of being made with this cold pressure weld
JP3046110B2 (en) Fiber-chitosan composite porous body, absorbent pad using the same, and chemical liquid impregnated pad
SE8405501D0 (en) PARTICULATE DIAGNOSTIC AGENT
GB975872A (en) Medical tampon for the treatment of cavities of the human body
SE8405500L (en) Diagnosis PARTICLES
Zborovsky et al. Immune tests with group A Streptococcus group-specific antigens in rheumatic fever.
KOIZUMI Analyses of Oligo-and Poly-Saccharides of Low Molecular Weight by High-Performance Liquid and Thin-Layer Chromatography
CA859419A (en) Process for the determination of glucose and fructose
AU454322B2 (en) IMPROVING THE HYDROPHILIC PROPERTIES and COHERENCE OF FIBRE ASSEMBLIES
AU437211B2 (en) Diagnostic agent for the detection of urobilinogen bodies in body fluids
BAILEY Research in support of aviation medicine(Research and development in Army aviation medical science and problems)[Annual Progress Report, 1 Jul. 1971- 30 Jun. 1972]

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7900738-1

Effective date: 19870228